- Open Access
Influence of pathogen and focus of infection on procalcitonin values in sepsis: are there additional confounding factors?
Critical Care volume 23, Article number: 215 (2019)
- The original article was published in Critical Care 2018 22:128
We read the study by Thomas-Rüddel et al. with great interest . Authors showed serum procalcitonin (PCT) concentrations were higher in patients with Gram-negative bacteremia (26 ng/ml) than in those with Gram-positive bacteremia (7.1 ng/ml) or candidemia (P < .0001) . They outlined some potential factors that could have impacted the PCT measurement outside to the type, location, and severity of the infection. In addition to their findings, it is essential to highlight that in patients with positive blood culture, septic shock is very common. Acute kidney injury (AKI) is prevalent among patients with sepsis, and a considerable proportion of patients with sepsis-associated AKI (SA-AKI) require renal replacement therapy (RRT) . As PCT has an approximate molecular weight of 14.5 kDa , the contemporary continuous RRT membranes are able to remove it (CRRT cutoff is about 35 kDa) . Also, using newer high adsorptive membranes (HAM) would make PCT removal even more prominent . Accordingly, if in the study by Thomas-Rüddel et al., there was any imbalance between the uses of CRRT between the two groups, it could critically impact the observed results. We, therefore, suggest including the use of CRRT in the prediction model. In addition, the design of future studies to assess the performance of PCT among septic patients who are on CRRT seems to be necessary .
Availability of data and materials
Acute kidney injury
Continuous renal replacement therapy
Highly adsorptive membranes
Renal replacement therapy
Thomas-Rüddel DO, Poidinger B, Kott M, Weiss M, Reinhart K, Bloos F; MEDUSA study group. Influence of pathogen and focus of infection on procalcitonin values in sepsis patients with bacteremia or candidemia. Crit Care 2018;22(1):128. doi: https://doi.org/10.1186/s13054-018-2050-9.
Peters E, Antonelli M, Wittebole X, Nanchal R, François B, Sakr Y, et al. A worldwide multicentre evaluation of the influence of deterioration or improvement of acute kidney injury on clinical outcome in critically ill patients with and without sepsis at ICU admission: results from The Intensive Care Over Nations audit. Crit Care. 2018;22(1):188. https://doi.org/10.1186/s13054-018-2112-z.
Level C, Chauveau P, Guisset O, Cazin MC, Lasseur C, Gabinsky C, et al. Mass transfer, clearance, and plasma concentration of procalcitonin during continuous venovenous hemofiltration in patients with septic shock and acute oliguric renal failure. Crit Care. 2003;6:R160–6.
Honoré PM, De Bels D, Spapen HD. An update on membranes and cartridges for extracorporeal blood purification in sepsis and septic shock. Curr Opin Crit Care. 2018;24(6):463–8. https://doi.org/10.1097/MCC.0000000000000542.
Honoré PM, Jacobs R, De Waele E, Van Gorp V, Spapen HD. Evaluating sepsis during continuous dialysis: are biomarkers still valid? Blood Purif. 2014;38(2):104–5. https://doi.org/10.1159/000363497 Epub 2014 Oct 17.
Ethics approval and consent to participate
Consent for publication
The authors declare that they have no competing interests.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
This comment refers to the article available at https://doi.org/10.1186/s13054-018-2050-9.
About this article
Cite this article
Honore, P.M., De Bels, D., Attou, R. et al. Influence of pathogen and focus of infection on procalcitonin values in sepsis: are there additional confounding factors?. Crit Care 23, 215 (2019). https://doi.org/10.1186/s13054-019-2499-1